.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
McKinsey
Queensland Health
Chinese Patent Office
Julphar
Medtronic
Farmers Insurance
Fish and Richardson

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,060,640

« Back to Dashboard

Details for Patent: 4,060,640

Title: Therapeutic agents
Abstract:O-HALOBENZYLIDENEAMINOGUANIDINES ARE EMPLOYED AS CENTRAL NERVOUS SYSTEM DEPRESSANTS, AS CARDIOVASCULAR DEPRESSANTS, AND/OR AS ANTIDEPRESSANTS FOR OVERCOMING PSYCHIC DEPRESSION.
Inventor(s): Kodama; Jiro K. (Herne Bay, EN), Haynes; George R. (Modesto, CA), Albert; James R. (Modesto, CA)
Assignee: Shell Oil Company (Houston, TX)
Filing Date:Jun 08, 1976
Application Number:05/693,998
Claims:1. A method of inducing a central nervous system depressant response in mammals to reduce hyperexcitability and induce sedation which comprises administering to a mammal an effective dosage for inducing a central nervous system depressant response of a compound of the formula ##STR4## wherein X is halogen or trifluoromethyl, Y and Z may be the same or different and each is hydrogen, halogen, trifluoromethyl or alkyl of 1 to 4 carbon atoms, R, R', R" and R.degree. each is hydrogen, alkyl of 1 to 4 carbon atoms, alkenyl of 2 to 4 carbon atoms or alkynyl of 2 to 4 carbon atoms with the proviso that R" and R.degree. may together form an ethylene or vinylene bridge, with the further proviso that one of Y and R must be hydrogen, or a pharmaceutically acceptable salt thereof.

2. A method according to claim 1 wherein X and Y each is chlorine, and Z, R, R', R" and R.degree. each is hydrogen, and the salt is a hydrochloric acid salt.

3. A method according to claim 1 wherein X and Y each is chlorine, and Z, R, R', R" and R.degree. each is hydrogen.

4. A method according to claim 1 wherein X and Y each is middle halogen and Z, R, R', R" and R.degree. each is hydrogen, and the salt is a hydrohalic acid salt.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Medtronic
Argus Health
McKesson
QuintilesIMS
UBS
Teva
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot